Alzheimer’s disease (AD) progression has also been associated with impaired reconsolidation and reduced BDNF signaling (Hock et al., 2000; Ohno, 2009), suggesting that increasing BDNF function during reconsolidation could partially counteract declarative memory deficits in AD patients. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.